alexa Hodgkin Lymphoma Survivor

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Hodgkin Lymphoma Survivor

If advances on radiotherapy allowed closing the page on poor Hodgkin Lymphoma prognosis, a new one opens dramatically on the long term effects, as second malignancies radiotherapy-related.

 

Citation: Brustia R, Delanian S, Scatton O (2015) Intrahepatic Cholangiocarcinoma in Hodgkin Lymphoma Survivor: Take it or Leave?. J Nucl Med Radiat Ther 6: 221. doi: 10.4172/2155-9619.1000221

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger